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SUMMARY
Angelman syndrome (AS) is a neurodevelopmental disorder caused by loss of the maternally
inherited allele of UBE3A. AS model mice, which carry a maternal Ube3a null mutation
(Ube3am−/p+), recapitulate major features of AS in humans, including enhanced seizure
susceptibility. Excitatory neurotransmission onto neocortical pyramidal neurons is diminished in
Ube3am−/p+ mice, seemingly at odds with enhanced seizure susceptibility. We show here that
inhibitory drive onto neocortical pyramidal neurons is more severely decreased in Ube3am−/p+
mice. This inhibitory deficit follows the loss of excitatory inputs and appears to arise from
defective presynaptic vesicle cycling in multiple interneuron populations. In contrast, excitatory
and inhibitory synaptic inputs onto inhibitory interneurons are largely normal. Our results indicate
that there are neuron type-specific synaptic deficits in Ube3am−/p+ mice despite the presence of
Ube3a in all neurons. These deficits result in excitatory/inhibitory imbalance at cellular and circuit
levels and may contribute to seizure susceptibility in AS.
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Angelman syndrome (AS) is characterized by severe intellectual disabilities, EEG
abnormalities, gait disturbances, disrupted sleep patterns, profound language impairment,
and autism (Williams et al., 2006). Seizures are present in 90% of AS patients, significantly
impacting their quality of life and that of their caregivers (Thibert et al., 2009). AS is caused
by deletions or loss-of-function mutations in the maternally inherited allele of UBE3A
(Rougeulle et al., 1997). UBE3A encodes an E3 ubiquitin ligase that, in the brain, is
expressed primarily from the maternal allele as a result of neuron-specific imprinting
(Albrecht et al., 1997). Similar to humans with AS, mice lacking maternal Ube3a
(Ube3am−/p+) have abnormal EEG activity and are susceptible to cortical seizures,
suggesting that loss of Ube3a might disrupt the excitatory/inhibitory balance in the
neocortex (Jiang et al., 1998).
Loss of maternally inherited Ube3a results in decreased excitatory synaptic drive onto
pyramidal neurons in layer 2/3 (L2/3) of neocortex, as evidenced by a loss of dendritic
spines (Yashiro et al., 2009). Decreased Ube3a-mediated proteasomal degradation of Arc
and Ephexin5 proteins may lead to excitatory synaptic defects (Greer et al., 2010; Margolis
et al., 2010). These observations suggest a mechanism for how the loss of Ube3a may cause
fewer and/or weaker excitatory synapses. While these deficits may be relevant to cognitive
phenotypes in Ube3am−/p+ mice, they would not on their own predict hyperexcitability and
increased seizure susceptibility. We hypothesized that Ube3a loss results in more severe
inhibitory deficits, with the net outcome favoring cortical hyperexcitability.
Here, we use the visual cortex as a model to study the role of Ube3a in the establishment and
function of inhibitory circuits. We show that Ube3am−/p+ mice have an abnormal
accumulation of clathrin-coated vesicles at inhibitory axon terminals, indicating a defect in
vesicle cycling. Consistent with this observation, inhibitory synaptic transmission onto L2/3
pyramidal neurons recovers slower following vesicle depletion in Ube3am−/p+ mice,
compared to wildtypes. Recovery following high-frequency stimulation of excitatory
synapses onto L2/3 pyramidal neurons, however, is normal. This discrepancy among
synapse types may further contribute to excitatory/inhibitory imbalance during high levels of
activity. Finally, we show that synaptic inputs onto inhibitory neurons in Ube3am−/p+ mice
are largely normal. We conclude that neuron type-specific synaptic deficits likely underlie
neocortical excitatory/inhibitory imbalance in AS.
RESULTS
Inhibitory Deficits in Mature Ube3am−/p+ Mice
An excitatory/inhibitory imbalance in AS could arise from reduced numbers of inhibitory
interneurons, abnormal inhibitory connectivity, and/or decreased inhibitory
neurotransmission. To test the first possibility, we performed immunohistochemistry for
three markers – parvalbumin, calretinin, and somatostatin – which together label 96% of the
total GABAergic interneurons in L2/3 of mouse primary visual cortex (V1) (Gonchar et al.,
2007). We compared Ube3am−/p+ mice and their wildtype (WT) 129Sv/Ev strain littermate
controls at postnatal day 80 (P80), an age where AS model mice exhibit abnormal EEG
patterns and are susceptible to seizures (Jiang et al., 1998). We found no differences in the
density of inhibitory interneurons expressing these markers (Figure 1A-B), implying that the
relative number of inhibitory interneurons is normal in L2/3 of V1.
Next we investigated the strength and number of inhibitory synapses onto L2/3 pyramidal
neurons. Using whole-cell voltage-clamp, we recorded miniature inhibitory postsynaptic
currents (mIPSCs) in the presence of tetrodotoxin to gauge spontaneous inhibitory synaptic
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activity onto excitatory L2/3 pyramidal neurons. We recorded mIPSCs at two ages: P25,
during the critical period for ocular dominance plasticity and when excitatory deficits have
been observed previously, and P80, when the visual cortex is fully mature. We observed no
difference in mIPSC amplitude between WT and Ube3am−/p+ mice at either P25 or P80,
suggesting that the loss of Ube3a did not change the strength of inhibitory synapses (Figure
1D; Table S1). While we saw no genotypic differences in mIPSC frequency at P25, L2/3
pyramidal neurons in Ube3am−/p+ mice had a reduction in mIPSC frequency by P80 (Figure
1E). These observations indicate that the loss of Ube3a leads to fewer functional inhibitory
synapses, or a reduction of their release probability onto L2/3 pyramidal neurons.
To further investigate the development of inhibitory inputs onto L2/3 pyramidal neurons, we
recorded evoked inhibitory postsynaptic currents (eIPSCs) using L4 stimulation at different
intensities in P25 and P80 Ube3am−/p+ and WT mice (Figure 1F). This type of stimulation
activates diverse inhibitory inputs and, with strong stimulation, can activate most of the
inhibitory inputs onto L2/3 pyramidal neurons (Morales et al., 2002). We saw no significant
difference in eIPSC amplitude at P25 (Figure 1G), but a large decrease in eIPSC amplitude
at P80 in Ube3am−/p+ mice compared to WT (Figure 1H). Together, these results confirm
that there is a severe deficit in the amount of inhibition arriving onto L2/3 pyramidal cells in
the mature visual cortex of Ube3am−/p+ mice.
In principle, a decrease in eIPSC amplitude could arise from reductions in the number of
postsynaptic GABA receptors, a decrease in the release probability of inhibitory axon
terminals, fewer functional inhibitory synapses, or a depolarized inhibitory interneuron
action potential threshold. It is unlikely that the decrease in eIPSC amplitude at P80 is due to
a decrease in the number of GABA receptors at active synapses, since the amplitude of
mIPSCs was similar in Ube3am−/p+ and WT mice. To assess whether the decrease in eIPSC
amplitude is due to the loss of functional synapses or to a decrease in release probability, we
examined the paired-pulse ratio of inhibitory inputs. Specifically, we stimulated L4 at
varying inter-pulse intervals to evoke IPSCs in L2/3 pyramidal cells, and compared the
paired-pulse ratio in WT and Ube3am−/p+ mice. We observed no difference in the paired-
pulse ratio between genotypes at either P25 or P80, implying that release at functional
inhibitory inputs onto L2/3 pyramidal cells is normal in response to brief stimuli given at
several interpulse intervals (Figure 1I). Finally, we found no difference in the action
potential threshold or intrinsic excitability of FS neurons (a major class of inhibitory
interneurons) in Ube3am−/p+ mice compared to WT, indicating that reduced eIPSC
amplitude is unlikely to be due to reductions in evoked action potentials in inhibitory
interneurons (Figure S1A-B). By exclusion, our data suggest a reduction in the total number
of functional inhibitory synapses.
Neuron type-specific Reduction in Functional Synapses in Ube3am−/p+ Mice
Our previous observations of reduced inhibition were made in Ube3am−/p+ mice on the
129Sv/Ev strain, which are susceptible to spontaneous seizures (Jiang et al., 1998), making
it difficult to determine whether the synaptic abnormalities were a cause or result of seizures
(Sloviter, 1987). To address this concern, we tested for possible synaptic deficits in
Ube3am−/p+ mice maintained on the C57BL/6J strain, which have a low incidence of evoked
seizures and no reported spontaneous seizures (Jiang et al., 1998). We performed mIPSC
recordings at P80 in WT and Ube3am−/p+ C57BL/6J mice to test if synaptic defects arose in
the absence of spontaneous seizures. As before, we observed no genotypic differences in the
amplitude of mIPSCs, but a large decrease in mIPSC frequency in Ube3am−/p+ mice (Figure
2A). We also performed mEPSC recordings in L2/3 pyramidal neurons in mice on the
C57BL/6J strain to confirm previous results from the 129Sv/Ev strain (Yashiro et al., 2009).
Consistent with previous results, there was a significant decrease in mEPSC frequency, but
not amplitude, between Ube3am−/p+ and WT mice (Figure 2B). These observations reveal
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that Ube3am−/p+ L2/3 pyramidal neurons have a 50% reduction in spontaneous inhibitory
synaptic activity, but only a 28% decrease in excitatory synaptic activity. Additionally,
intrinsic excitability was of L2/3 pyramidal neurons was increased in Ube3am−/p+ mice
compared to WT (Figure S1C). Together these data suggest that a disproportionate loss of
inhibition may lead to an excitatory/inhibitory imbalance in Ube3am−/p+ L2/3 pyramidal
neurons.
Ube3a is expressed by both excitatory and inhibitory interneurons in the cerebral cortex
(Sato and Stryker, 2010). Therefore, Ube3a loss might be expected to affect both neuron
classes. To assess this possibility, we recorded spontaneous synaptic activity in fast-spiking
(FS) inhibitory interneurons, which we identified by membrane properties, aspinous
dendrites, and characteristic high firing rates (Okaty et al., 2009). FS inhibitory interneurons
in L2/3 were targeted for whole-cell recording at P80, an age at which excitatory and
inhibitory neurotransmission onto L2/3 pyramidal neurons is altered. In contrast to L2/3
pyramidal neurons, the loss of Ube3a did not affect either the amplitude or the frequency of
mIPSCs onto FS inhibitory interneurons (Figure 2C). Moreover, excitatory connections onto
FS inhibitory interneurons appeared normal, as Ube3a loss did not alter mEPSC amplitude
or frequency (Figure 2D). Similar to L2/3, Ube3a loss did not change the frequency or
amplitude of mIPSCs or mEPSCs onto L5/6 FS inhibitory interneurons (Figure S2A-B).
These results imply that Ube3a loss has neuron type-specific synaptic effects.
Ube3a Loss Results in Inhibitory Deficits from FS Interneurons
We examined the effects of Ube3a loss on FS inhibitory interneurons, which provide the
majority of perisomatic inhibitory input to L2/3 pyramidal neurons (Jiang et al., 2010),
impart feed-forward and feedback inhibition, and have been implicated in seizure
susceptibility (Di Cristo et al., 2004). Despite the challenge of performing paired recordings
in adult neocortical slices, we were able to investigate synaptic connectivity between 83
pairs of L2/3 FS inhibitory interneurons and L2/3 pyramidal neurons in WT and Ube3am−/p+
mice at P80 (Table S3).
We first analyzed synaptic connectivity from FS inhibitory interneurons to pyramidal
neurons. Using current-clamp recordings, we evoked action potentials in FS interneurons
with depolarizing current injections at 30 Hz, and simultaneously recorded the response in
pyramidal neurons (Figure 3A). To measure short-term plasticity we normalized the
amplitude of the evoked IPSPs to the amplitude of the first IPSP in the train. We observed
no change in the short-term plasticity between genotypes (Figure 3B). However, the
amplitude of the first IPSP between these pairs was significantly decreased in Ube3am−/p+
mice, indicating decreased connection strength from FS inhibitory interneurons to L2/3
pyramidal neurons (Figure 3C). We also found a 31% decrease in connection probability in
Ube3am−/p+ mice compared to WT mice (Figure 3D), supporting the conclusion that the
decreased IPSP amplitude is likely due to a reduction in the number of functional synapses
made from FS interneurons to pyramidal neurons. Finally, we estimated the average
inhibitory drive from FS inhibitory interneurons onto L2/3 pyramidal neurons, by
calculating the product of connection strength and connection probability, finding that
inhibitory drive was reduced by 71% in Ube3am−/p+ mice compared to WT mice (Figure
3E).
To further investigate possible effects of Ube3a loss on synaptic connectivity, we examined
the connections from L2/3 pyramidal neurons to FS inhibitory interneurons. We measured
short-term plasticity and found that Ube3am−/p+ mice had increased facilitation at synapses
from pyramidal neuron to FS interneurons (Figure S3B). To assess connection strength in
this pathway, we measured the amplitude of the first EPSP evoked in the postsynaptic FS
interneuron, detecting no difference between genotypes (Figure S3C). Finally, we found no
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genotypic difference in the connection probability of L2/3 pyramidal to FS inhibitory
interneuron pairs (Figure S3D).
These data suggest that, while excitatory connection frequency and strength onto L2/3 FS
interneurons are unchanged in Ube3am−/p+ mice, excitatory inputs onto FS inhibitory
interneurons have altered short-term plasticity, potentially leading to defective engagement
of FS inhibitory interneurons during trains of activity. The unchanged strength of the
pyramidal to FS inhibitory interneuron connections in Ube3am−/p+ mice was unexpected,
since short-term plasticity measurements indicated a change in release probability at this
synapse. We conclude that other factors, such as differences in calcium buffering, coupling
of calcium channels to release machinery, or vesicular trafficking, must underlie the
observed changes (Atwood and Karunanithi, 2002). Together, these experiments identify a
specific inhibitory interneuron subtype, FS inhibitory interneurons, that is at least partially
responsible for the decrease in inhibition found in L2/3 pyramidal neurons in the AS model.
Ube3a Loss Results in Inhibitory Deficits from Non-FS Interneurons
L2/3 pyramidal neurons receive inhibition from a variety of inhibitory interneuron subtypes
(Markram et al., 2004). To test whether inhibitory deficits in Ube3am−/p+ mice could also be
ascribed to other types of interneurons, we used agatoxin, a potent irreversible antagonist of
P/Q-type voltage-gated calcium channels (VGCCs), to block release of GABA selectively
from FS inhibitory interneurons (Jiang et al., 2010). Agatoxin suppressed about 90% of the
total eIPSCs in both WT and Ube3am−/p+ mice 20 minutes after perfusion of the toxin
(Figure 3G). The agatoxin-insensitive portion of the eIPSC had an increased latency from
stimulation onset and an increased rise time, suggesting that the agatoxin-insensitive inputs
targeted the distal dendrites of L2/3 pyramidal neurons (Figure S3G-H). Agatoxin-
insensitive inputs also had decreased paired-pulse depression compared to the total eIPSC, a
signature of non-FS inhibitory interneurons (Figure S3F) (Gupta et al., 2000). After agatoxin
perfusion, we recorded eIPSCs at different stimulation intensities and again found a decrease
in the strength of inhibitory inputs in the Ube3am−/p+ mice, compared to WT, demonstrating
that Ube3a loss also affects inputs from non-FS classes of inhibitory interneurons (Figure
3H).
Ube3am−/p+ mice have Defects in Synaptic Vesicle Cycling
Our electrophysiological data suggest that inhibitory deficits in Ube3am−/p+ mice result from
a loss of functional inhibitory synapses onto L2/3 pyramidal neurons. However, a reduction
in functional synapses could arise anatomically from fewer synaptic contacts,
postsynaptically by a loss of functional receptors, or presynaptically by a severe depletion of
releasable synaptic vesicles rendering a subset of inhibitory axon terminals non-functional.
To test for an anatomical correlate to our functional data, we used immunohistochemistry to
stain WT and Ube3am−/p+ mice for the vesicular GABA transporter (VGAT), a marker for
the axon terminals of inhibitory interneurons (Chaudhry et al., 1998). We were surprised to
see similar densities of VGAT-positive puncta in WT and Ube3am−/p+ mice, suggesting no
change in the number of inhibitory interneuron axon terminals (Figure S4A-C). However,
there remained the possibility that some of these axon terminals were nonfunctional. To
explore this possibility, we used electron microscopy to examine synaptic structure in WT
and Ube3am−/p+ mice. Post-embedding immunogold localization of GABA was used to
identify inhibitory synapses onto somata in L2/3 of V1. The area of GABA-positive axon
terminals and proportion of mitochondria per terminal were not different between WT and
Ube3am−/p+ mice (Figure 4A2-A3). However, there was a decrease in the number of synaptic
vesicles, and a large increase in the number of clathrin-coated vesicles (CCVs), in the
Ube3am−/p+ mice compared to WT (Figure 4A4-A5, S4F-G). We also tested whether the
defects we observed in inhibitory synapses were generalized to excitatory synapses. Similar
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to inhibitory synapses, we observed a decrease in the number of synaptic vesicles, but no
change in the area of excitatory axon terminals or the proportion of mitochondria per
terminal (Figure 4B1-B4, S4D-E). Finally, we saw little or no decrease in the number of
CCVs at excitatory synapses between genotypes (Figure 4B5, S4D-E). These data suggest a
defect in synaptic vesicle cycling in inhibitory synapses of Ube3am−/p+ mice.
Incomplete Recovery of IPSCs after High-Frequency Stimulation in Ube3am−/p+ mice
Previous studies examining synaptic vesicle cycling have identified genes whose mutation
leads to increased numbers of CCVs in axon terminals (Slepnev and De Camilli, 2000).
Many of these mutant synapses maintain the ability to release neurotransmitter and have
normal short-term plasticity; however, during periods of high activity these synapses fail to
adequately replenish their synaptic vesicle pool, resulting in a delayed recovery to baseline
levels of transmitter release (Luthi et al., 2001). These studies led us to test if inhibitory
synapses in the Ube3am−/p+ mice had functional deficits similar to other synaptic vesicle
cycling mutants. We applied a train of 800 stimuli at 10 Hz while recording eIPSCs in L2/3
pyramidal neurons in WT and Ube3am−/p+ mice (Figure 4C). We then decreased the
stimulation frequency to 0.33 Hz and recorded the recovery phase of the eIPSC (Figure
4C1). Ube3a loss had no effect on the depletion phase of the eIPSC (Figure 2C2) in
agreement with our previous experiments examining short-term plasticity (Figure 1I and
3B). However, we found a large decrease in the rate and level of recovery of the eIPSC in
Ube3am−/p+ mice compared to WT (Figure 4C3). These data are consistent with defects in
inhibitory synaptic vesicle cycling in Ube3am−/p+ mice. Specifically, the decrease in
recovery of the eIPSC, combined with the increase in CCVs, suggests an inability of newly
endocytosed CCVs to reenter and replenish the synaptic vesicle pool. These defects may
render a subset of inhibitory synapses nonfunctional in Ube3am−/p+ mice.
Finally, we challenged excitatory synapses with the same high frequency stimulation
protocol that we used to test inhibitory synapses (Figure 4D1). Unlike inhibitory synapses,
Ube3a loss did not have an effect on the recovery of excitatory synapses from high-
frequency stimulation (Figure 4D3). Thus, the pronounced accumulation of CCVs observed
at inhibitory synapses correlates well with the selective deficits in the synaptic recovery
from high-frequency stimulation. Moreover, these functional data demonstrate that
following a high-frequency train of activity a period of heightened excitatory/inhibitory
imbalance may occur in this circuit.
DISCUSSION
This work represents the first demonstration that maternal loss of Ube3a, as seen in
individuals with AS, leads to neuron type-specific synaptic deficits. Our findings suggest
that loss of Ube3a can result in an excitatory/inhibitory imbalance in the neocortex.
Earlier studies showing decreased excitatory neurotransmission in Ube3am−/p+ mice were
difficult to reconcile with reports of high seizure susceptibility (Jiang et al., 1998; Yashiro et
al., 2009). Our data provides clarification, showing that the loss of Ube3a causes a
particularly severe decrease in inhibitory input to L2/3 pyramidal neurons. We also report
that AS model mice have a synaptic vesicle cycling defect, which suggests a basis for this
deficit. The vesicle cycling defects we observe are similar to those observed after deletion of
the presynaptic proteins synaptojanin (Cremona et al., 1999) or endophilin (Milosevic et al.,
2011), both which lead to increased CCVs at synaptic terminals, and decreased synaptic
recovery from high levels of activity. Notably, inhibitory synapses may be particularly
sensitive to disruptions in vesicular trafficking, due to their enhanced activity and smaller
vesicle pools (Hayashi et al., 2008). These results, combined with our functional studies
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describing defective inhibitory synaptic transmission in Ube3am−/p+ mice, suggest a means
by which a hyperexcitable cortical circuit could arise despite fewer excitatory synapses.
Ube3a is present in both excitatory and inhibitory interneurons in the brain (Sato and
Stryker, 2010). Our results showing different synaptic defects onto excitatory and inhibitory
neurons indicate Ube3a deficiency causes neuron type-specific deficits. Since, Ube3a targets
its substrate proteins for proteasomal degradation, the consequences of Ube3a loss may
depend on which substrate proteins are normally present in a cell. This hypothesis is
supported by recent work showing that Arc, a protein expressed postsynaptically in
excitatory but not inhibitory interneurons, is a Ube3a substrate (Greer et al., 2010; McCurry
et al., 2010). Thus, the loss of Ube3a is expected to cause an inappropriate overexpression of
Arc in excitatory neurons without affecting inhibitory interneurons. Given the ability of Arc
to influence AMPA receptor endocytosis (Chowdhury et al., 2006), the neuron type-specific
expression of Arc could partly explain the excitatory synaptic defects observed onto L2/3
pyramidal neurons and the lack of effect in FS interneurons. Conversely, our findings
suggest a novel synaptic defect in Ube3am−/p+ mice at inhibitory synapses, primarily
affecting presynaptic function at inhibitory synapses and resulting in fewer functional
synapses. Intriguingly, the observed excitatory and inhibitory defects both involve endocytic
processes, albeit at different sides of the synaptic cleft, suggesting common processes may
be involved.
Altered function of GABA receptors and/or inhibitory interneurons has been hypothesized to
underlie many of the phenotypes seen in AS (Dan and Boyd, 2003). While attention has
focused on how defects in GABAergic neurotransmission may relate to epileptic phenotypes
in AS, abnormalities in inhibition can have wide-ranging consequences, including disrupting
synaptic plasticity, cortical network oscillations, and cortical circuit architecture (Cardin et
al., 2009; Hensch, 2005). For example, FS inhibitory interneurons have a critical role in
ocular dominance plasticity (Hensch et al., 1998), which is severely reduced in Ube3am−/p+
mice (Sato and Stryker, 2010; Yashiro et al., 2009). Our finding that inhibitory interneuron
to L2/3 pyramidal neuron connections are altered in Ube3am−/p+ mice may prove important
for understanding the mechanisms underlying plasticity and learning defects in AS.
Understanding the specific synaptic impairments caused by the global loss of Ube3a may
provide insights into the intractable nature of seizures found in many individuals with AS.
Excitatory/inhibitory imbalance has been observed in several genetic disorders that meet
diagnostic criteria for autism spectrum disorders, including neuroligin-3 mutation, Fragile X,
and Rett syndrome (Dani et al., 2005; Gibson et al., 2008; Tabuchi et al., 2007). Moreover,
excitatory/inhibitory imbalance may be a general neurophysiological feature of autism
spectrum disorders, contributing to inappropriate detection or integration of salient sensory
information due to a decreased signal-to-noise ratio (Rubenstein and Merzenich, 2003). Our
finding that an excitatory/inhibitory imbalance may develop in AS due to the loss of
functional inhibitory synapses highlights the importance of identifying Ube3a substrates in
inhibitory interneurons.
EXPERIMENTAL PROCEDURES
See Supplemental Experimental Procedures for details relating to electrophysiology and
immunohistochemistry.
Animals
Ube3a-deficient mice on the 129Sv/Ev background were originally developed by Jiang and
colleagues (Jiang et al., 1998) and obtained through the Jackson Laboratory (Bar Harbor,
ME). Ube3a-deficient mice backcrossed onto the C57BL/6J background were obtained from
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Yong-hui Jiang (Duke University) and crossed with mice expressing GFP in a subset of FS
inhibitory neurons (Chattopadhyaya et al., 2004) obtained through Jackson Laboratory.
Statistics
Most experiments and analyses were performed blind to genotype. Unpaired students t-tests
were used on all data excluding the following; input-output, frequency-current, short-term
plasticity, connection probability and for depletion and recovery experiments. Graphs
represent the mean and error bars represent the SEM. For all figures p-values are as follows
*p<0.05, **p<0.01, ***p<0.001. All statistics were performed in Graphpad Prism.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1. Inhibitory synaptic deficits arising through development in Ube3am−/p+ mice are not
due to decreased density of inhibitory interneurons
(A) Photomicrographs of immunocytochemical markers for inhibitory interneurons in visual
cortex of wildtype (WT) and Ube3a-deficient (m−/p+) mice. (B) Quantification of
parvalbumin, calretinin, and somatostatin positive neurons in L2/3 of mouse primary visual
cortex at ~P80 (n=4 mice/genotype). (C) Sample mIPSC recordings from ~P25 (P21-P28)
and ~P80 (P70-P90) WT and Ube3am−/p+ mice (scale bar = 30 pA, 400 ms). (D) Average
mIPSC amplitude was similar between WT and Ube3am−/p+ mice at ~P25 (WT n=10 cells;
m−/p+ n=8 cells) and ~P80 (n=13 cells/genotype) in L2/3 pyramidal cells. (E) Average
mIPSC frequency for ~P25 (WT n=10 cells; m−/p+ n=8 cells) and ~P80 (n=13 cells/
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genotype) (see also Table S1). (F) Illustration of stimulation (L4) and recording (L2/3
pyramidal neuron) configuration in primary visual cortex, and sample recordings of evoked
IPSCs at stimulation intensities of 0, 10, 30, and 100 μA (scale bar = 500 pA, 30 ms). (G)
Evoked IPSCs at ~P25 (WT n=26 cells; m−/p+ n=29 cells) and (H) ~P80 (WT n=20 cells; m
−/p+ n=14 cells). (I) Sample recordings of evoked IPSCs in paired-pulse experiments (scale
bar = 100pA, 20 ms) and quantification of paired-pulse ratio in mice aged ~P25 (WT n=12
cells; m−/p+ n=11 cells) and ~P80 (WT n=13 cells; m−/p+ n=8 cells.) (see also Figure S1).
All data are represented as the mean ± SEM; **p<0.01, ***p<0.001.
Wallace et al. Page 12













Figure 2. Ube3a loss leads to neuron type-specific defects in inhibitory neurotransmission
(A1) Illustration and photomicrograph of a filled L2/3 pyramidal neuron and sample
recordings from ~P80 WT (upper) and Ube3am−/p+ (lower) mice (scale bar = 40 pA, 300
ms.) (A2) Average mIPSC amplitude (n=11 cells/genotype, p=0.16) and (A3) frequency
(n=11 cells/genotype) from L2/3 pyramidal neurons. (B1) Illustration and fill of a L2/3
pyramidal neuron and sample recordings from ~P80 WT (upper) and Ube3am−/p+ (lower)
mice (scale bar 15 pA, 300 ms). (B2) Average mEPSC amplitude (WT n=6 cells; m−/p+ n=9
cells) and (B3) frequency (WT n=6 cells; m−/p+ n=9 cells) from L2/3 pyramidal neurons.
(C1) Illustration and fill of a L2/3 FS inhibitory interneuron and sample recordings from
~P80 WT (upper) and Ube3am−/p+ (lower) mice (scale bar 40 pA, 300 ms). (C2) Average
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mIPSC amplitude (WT n=13 cells; m−/p+ n=10 cells) and (C3) frequency (WT n=13 cells;
m−/p+ n=10 cells; p=0.57) from L2/3 FS inhibitory interneurons. (D1) Illustration and fill of
a L2/3 FS inhibitory interneuron and sample recordings from ~P80 WT (upper) and
Ube3am−/p+ (lower) mice (scale bar 10 pA, 300 ms). (D2) Average mEPSC amplitude (WT
n=13 cells; m−/p+ n=12 cells) and (D3) frequency (WT n=13 cells; m−/p+ n=12 cells) from
L2/3 FS inhibitory interneurons (see also Figure S2 and Table S2). Bar graphs represent the
mean ± SEM; p*<0.05, p***<0.001.
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Figure 3. Synaptic deficits arise from both FS and non-FS inhibitory interneurons in Ube3am−/p+
mice
(A) Recording configuration (upper) and representative recordings of presynaptic action
potentials evoked in a FS inhibitory interneuron (middle), and resulting unitary IPSPs in a
L2/3 pyramidal neuron (lower) from WT (blue) and Ube3am−/p+ mice (red). Average is of
12 trials. Scale bar “Pre” 20 mV, 40 ms; “Post” 4 mV, 40 ms. (B) Average short-term
plasticity of inhibitory to excitatory connections (WT n=8; m−/p+ n=12) (presynaptic spikes
@ 30 Hz). (C) Average unitary IPSP amplitude of 1st IPSP of inhibitory to excitatory
connections (WT n=8; m−/p+ n=12). (D) Connection probability of FS inhibitory
interneurons to L2/3 pyramidal neurons (numbers of connected/total pairs written in bars);
(E) inhibitory drive of FS inhibitory interneurons to L2/3 pyramidal neurons (WT n=19
pairs; m−/p+ n=30 pairs). (F) Recording configuration (upper) and representative recordings
(lower) of eIPSCs during baseline (black) and 20 minutes after 500 nM ω-agatoxin-IVa
perfusion (green) (scale bar = 100 pA, 20 ms). (G) A 10 minute baseline was recorded
before a 10 minute perfusion of agatoxin (green bar) (WT n=10; m−/p+ n=10). (H) Input-
output relationship in the agatoxin-insensitive portion of total eIPSC performed 20 minutes
after cessation of agatoxin perfusion (WT n=10; m−/p+ n=10). (see also Figure S3 and
Table S3). Data are represented as the mean ± SEM; *p<0.05, **p<0.01, ***p<0.001.
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Figure 4. Inhibitory synapses of Ube3am−/p+ mice have presynaptic defects
(A1) Electron micrographs of inhibitory synapses stained for GABA in ~P80 WT and
Ube3am−/p+ mice (green denotes axon terminal, blue denotes soma), insets highlight CCVs
(scale bar = 250 nm). Average values of (left to right) (A2) axon terminal area, (A3)
mitochondrial area divided by terminal area, (A4) number of synaptic vesicles per square
micron, and (A5) number of CCVs per square micron (WT n = 3; m−/p+ n = 4). (B1)
Electron micrographs of excitatory synapses in WT and Ube3am−/p+ mice (green denotes
axon terminal, red denotes spine) (scale bar = 250 nm). Average values of (left to right) (B2)
axon terminal area, (B3) mitochondrial area divided by terminal area, (B4) number of
synaptic vesicles per square micron, and (B5) number of CCVs per square micron (WT n =
3; m−/p+ n = 4). (C1) Sample recordings (left) and sample experiment (right) showing
baseline (black), high frequency depletion (orange), and recovery (black) phases (scale bars;
baseline = 200 pA, 20 ms; depletion = 200 pA, 200 ms; recovery = 200 pA, 20 ms). (C2)
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Average depletion phase showing eIPSC amplitude normalized to baseline during 800
stimuli at 10 Hz. 10 responses are averaged for each point and a monophasic exponential
was fit to the averaged responses for WT and Ube3am−/p+ mice (WT n=19; m−/p+ n=18).
(C3) Average recovery phase showing eIPSC amplitude normalized to baseline during 90
stimuli at 0.33 Hz. 3 responses are averaged for each point and a monophasic exponential
was fit to the averaged responses for WT and Ube3am−/p+ mice (WT n=19; m−/p+ n=18).
(D1) Sample recordings (left) and sample experiment (right) showing baseline (black), high
frequency depletion (orange), and recovery (black) phases (scale bars; baseline = 100 pA, 10
ms; depletion = 100 pA, 200 ms; recovery = 100 pA, 10 ms). (D2) Average depletion phase
showing eEPSC amplitude normalized to baseline during 800 stimuli at 10 Hz. 10 responses
are averaged for each point and a monophasic exponential was fit to the averaged responses
for WT and Ube3am−/p+ mice (WT n=10; m−/p+ n=11). (D3) Average recovery phase
showing eEPSC amplitude normalized to baseline during 90 stimuli at 0.33 Hz. 3 responses
are averaged for each point and a monophasic exponential was fit to the averaged responses
for WT and Ube3am−/p+ mice (WT n=10; m−/p+ n=11) (see also Figure S4). Data are
represented as the mean ± SEM; *p<0.05, ***p<0.001.
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